First PREMIER Bank’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

First PREMIER Bank’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60K	Hold	670	–	–	0.01%	225
2026 Q1	$53K	Hold	670	–	–	0.01%	225
2025 Q4	$55K	Hold	670	–	–	0.01%	224
2025 Q3	$47K	Hold	670	–	–	0.01%	234
2025 Q2	$43K	Hold	670	–	–	0.01%	236
2025 Q1	$43K	Hold	670	–	–	0.01%	235
2024 Q4	$45K	Hold	670	–	–	0.01%	227
2024 Q3	$47K	Hold	670	–	–	0.01%	238
2024 Q2	$43K	Hold	670	–	–	0.01%	219
2024 Q1	$43K	Hold	670	–	–	0.01%	219
2023 Q4	$44K	Hold	670	–	–	0.01%	220
2023 Q3	$38K	Hold	670	–	–	0.01%	229
2023 Q2	$41K	Hold	670	–	–	0.01%	236
2023 Q1	$42K	Buy	+670	New	+$43.2K	0.01%	243

Other funds holding PBE

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

NDSI

Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

First PREMIER Bank's PBE Position: Q2 2026 in Review

First PREMIER Bank held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q2 2026 at 670 shares worth $60K. The position accounts for 0.01% of the portfolio, ranked #225.

First PREMIER Bank first reported a position in PBE in Q1 2023 and has held it in 14 quarters since. 9 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

First PREMIER Bank held 670 shares of Invesco Biotechnology & Genome ETF worth $60K as of Q2 2026.
First PREMIER Bank left its Invesco Biotechnology & Genome ETF share count unchanged in Q2 2026.
Invesco Biotechnology & Genome ETF made up 0.01% of First PREMIER Bank's portfolio in Q2 2026, its #225 holding.
First PREMIER Bank first reported a position in Invesco Biotechnology & Genome ETF in Q1 2023 and has held it in 14 quarters since.
9 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.